Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroimaging and CBD for Opioid Use Disorder
NCT04567784Phase 2Completed
- Start
- Nov 2020
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in opioid use disorder (OUD). Started Nov 2020; status: completed.
02
Drugs
cannabidiol
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04567784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04567784.